Enhanced Anti-Inflammatory Effects of Rosemary (Salvia rosmarinus) Extracts Modified with Pseudomonas shirazensis Nanoparticles
Antioxidants · 29.07.2025 · 14 (8) · 931
DOI: 10.3390/antiox14080931 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antioxidants, online erschienen am 29.07.2025. Verfasst von Enrique Gutierrez-Albanchez und 4 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy, Universidad San Pablo-CEU Universities, 28040 Madrid, Spain. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Marie Skłodowska-Curie Actions fellowship, International Seal award of University San Pablo CEU.
Abstract (Originalsprache)
Rosemary (Salvia rosmarinus) is renowned for its antioxidant, anti-inflammatory, and antihyperglycemic properties, largely attributed to its rich phytochemical profile. This study evaluates the potential of metabolites from Pseudomonas shirazensis NFV3, formulated in silver nanoparticles (AgNPs), to enhance the bioactivity of rosemary extracts in postharvest applications. Rosemary stems were treated with AgNPs coated with bacterial metabolites (NP), bacterial cells, or metabolites (LM), and the extracts’ phytochemical composition and bioactivities were assessed. HPLC and HPLC–MS analyses revealed that the NP treatment induced significant metabolic remodeling, particularly upregulating rosmarinic acid and selected triterpenes (ursolic and betulinic acids), while reducing carnosic acid levels. NP-treated extracts exhibited significantly enhanced inhibition of cyclooxygenase (COX-1 and COX-2), indicating improved anti-inflammatory potential. The α-glucosidase inhibition and antioxidant activity (DPPH assay) of the extracts were not substantially altered, suggesting the selective enhancement of pharmacological functions. These findings demonstrate that nanoparticle-based elicitation selectively remodels secondary metabolism in rosemary, improving extract quality and bioactivity. This strategy offers a novel, sustainable tool for optimizing plant-based therapeutics in the phytopharmaceutical industry.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Pharmacy, Universidad San Pablo-CEU Universities, 28040 Madrid, Spain.
- Institute of Food Biotechnology and Genomics, NAS of Ukraine, 01112 Kyiv, Ukraine.
ORCID-Profile: Enrique Gutierrez-Albanchez, Elena Fuente-González, Svitlana Plokhovska, Francisco Javier Gutierrez-Mañero, Beatriz Ramos-Solano
Förderung
- Marie Skłodowska-Curie Actions fellowship
- International Seal award of University San Pablo CEU
Zitieren
APA
Gutierrez-Albanchez, E., Fuente-González, E., Plokhovska, S., Gutierrez-Mañero, F. J., & Ramos-Solano, B. (2025). Enhanced Anti-Inflammatory Effects of Rosemary (Salvia rosmarinus) Extracts Modified with Pseudomonas shirazensis Nanoparticles. Antioxidants, 14(8), 931. https://doi.org/10.3390/antiox14080931
Vancouver
Gutierrez-Albanchez E, Fuente-González E, Plokhovska S, Gutierrez-Mañero FJ, Ramos-Solano B. Enhanced Anti-Inflammatory Effects of Rosemary (Salvia rosmarinus) Extracts Modified with Pseudomonas shirazensis Nanoparticles. Antioxidants. 2025;14(8):931. doi:10.3390/antiox14080931
BibTeX
@article{GutierrezAlbanchez2025,
author = {Gutierrez-Albanchez, Enrique and Fuente-González, Elena and Plokhovska, Svitlana and Gutierrez-Mañero, Francisco Javier and Ramos-Solano, Beatriz},
title = {Enhanced Anti-Inflammatory Effects of Rosemary (Salvia rosmarinus) Extracts Modified with Pseudomonas shirazensis Nanoparticles},
journal = {Antioxidants},
year = {2025},
volume = {14},
number = {8},
pages = {931},
doi = {10.3390/antiox14080931}
}
EUVIMED